Oduah, E., Saltos, A. N., Stinchcombe, T., Concepcion, J. R., Crawford, J., Clarke, J. M., Alder, L., Oswalt, C., Wolf, S., Jung, S., Owzar, K., Qin, X., Ireland, A., Chen, A., Lyniv, L., Ready, N. E., Gray, J. E., Oliver, T. G., Antonia, S. J. (2026). Alirocumab plus cemiplimab in immuno-refractory metastatic NSCLC: A single-arm, multi-center, phase 2 study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.2619